L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Kommoss, Felix KF, Karnezis, Anthony N., Kommoss, Friedrich, Talhouk, Aline, Taran, Florin-Andrei, Staebler, Annette, Gilks, C. Blake, Huntsman, David G., Krämer, Bernhard, Brucker, Sara Y., McAlpine, Jessica N., Kommoss, Stefan
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134076/
https://ncbi.nlm.nih.gov/pubmed/30050154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0187-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki